MacroGenics
MGNX
$5.12
Share price
8.70%
Change (1 day)
-15.65%
Change (1 year)
Categories
Number of shares outstanding for MacroGenics (MGNX)
Number of shares outstanding as of May 2024 : 61,980,680
According to MacroGenics's latest financial reports and stock price the company's current number of shares outstanding is 61,980,680. At the end of 2023 the company had 61,980,680 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for MacroGenics from 2012 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 61.98 M | 0.85% |
| 2022 | 61.45 M | 0.47% |
| 2021 | 61.16 M | 12.31% |
| 2020 | 54.46 M | 11.37% |
| 2019 | 48.9 M | 15.78% |
| 2018 | 42.23 M | 14.85% |
| 2017 | 36.77 M | 5.79% |
| 2016 | 34.76 M | 4.28% |
| 2015 | 33.33 M | 20.13% |
| 2014 | 27.75 M | 15.53% |
| 2013 | 24.02 M | 32.42% |
| 2012 | 18.14 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 9,010.90% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | 1,431.73% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | 763.17% | 🇺🇸 USA |
 Gilead Sciences GILD | 1,248,000,000 | 1,913.53% | 🇺🇸 USA |
 Merck MRK | 2,554,166,667 | 4,020.91% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,023,000,000 | 3,163.92% | 🇺🇸 USA |
 Xencor XNCR | 60,621,534 | -2.19% | 🇺🇸 USA |